GAINESVILLE, Fla.--(BUSINESS WIRE)--Banyan Biomarkers, Inc., the leader in developing blood-test based, point-of-care diagnostic products to detect traumatic brain injury (TBI), has appointed Mel Rothberg and John N. Spencer, Jr. to the company’s board of directors.
